Table 1.
2005–2007 (n = 3,580) |
2012–2014 (n = 4,287) |
|||
---|---|---|---|---|
Characteristics | n | (%) | n | (%) |
Stage | ||||
Stage I | 1,951 | 54.5% | 2,442 | 57.0% |
Stage II | 1,299 | 36.3% | 1,439 | 33.6% |
Stage III | 330 | 9.2% | 406 | 9.5% |
Chemotherapy | 1,306 | 36.5% | 1,555 | 36.3% |
Radiation therapy | 1,015 | 28.4% | 2,071 | 48.3% |
Age at diagnosis | ||||
< 50 yrs | 641 | 17.9% | 764 | 17.8% |
50–59 yrs | 1,005 | 28.1% | 1,074 | 25.1% |
60–69 yrs | 989 | 27.6% | 1,391 | 32.4% |
70–84 yrs | 858 | 24.0% | 948 | 22.1% |
>=85 yrs | 87 | 2.4% | 110 | 2.6% |
Race/Ethnicity | ||||
Asian/Pacific Islander | 461 | 12.9% | 707 | 16.5% |
African American | 214 | 6.0% | 272 | 6.3% |
Hispanic | 391 | 10.9% | 498 | 11.6% |
Native American/Other | 4 | 0.1% | 15 | 0.3% |
Unknown | 2 | 0.1% | 8 | 0.2% |
Non-Hispanic White | 2,508 | 70.1% | 2,787 | 65.0% |
Median household income | ||||
< 50K | 652 | 18.2% | 737 | 17.2% |
50–<100K | 1,950 | 54.5% | 2,315 | 54.0% |
100K+ | 973 | 27.2% | 1,235 | 28.8% |
Unknown | 5 | 0.1% | 0 | 0.0% |
Education: less than high schoola | ||||
< 10% | 2,910 | 81.3% | 3,463 | 80.8% |
10–<20% | 457 | 12.8% | 576 | 13.4% |
20+% | 208 | 5.8% | 248 | 5.8% |
Unknown | 5 | 0.1% | 0 | 0.0% |
Education: high schoolb | ||||
< 10% | 444 | 12.4% | 503 | 11.7% |
10–<20% | 889 | 24.8% | 1,088 | 25.4% |
20+% | 2,242 | 62.6% | 2,696 | 62.9% |
Unknown | 5 | 0.1% | 0 | 0.0% |
Education: more than high schoolc | ||||
< 25% | 43 | 1.2% | 63 | 1.5% |
25–<50% | 512 | 14.3% | 627 | 14.6% |
50+% | 3,020 | 84.4% | 3,597 | 83.9% |
Unknown | 5 | 0.1% | 0 | 0.0% |
Income and education are based on U.S. Census block of residence. To interpret the “Education: less than high school” variable, 81.3% of patients in the pre-outreach period (diagnosis in 2005–2007) lived in a Census block in which <10% had less than high school education.